Time sequence of maturation of dystrophic neurites associated with Aβ deposits in APP/PS1 transgenic mice

Experimental Neurology

Volumn 184, Issue 1, 2003, Pages 247-263

  Blanchard, Véronique ^a   Moussaoui, Saliha ^a,d   Czech, Christian ^a,e   Touchet, Nathalie ^a   Bonici, Bruno ^a   Planche, Michel ^a   Canton, Thierry ^a   Jedidi, Iness ^a   Gohin, Micheline ^a   Wirths, Oliver ^b   Bayer, Thomas A ^b   Langui, Dominique ^c   Duyckaerts, Charles ^c   Tremp, Günter ^a   Pradier, Laurent ^a  

^a SANOFI   (France)

^b SAARLAND UNIVERSITY   (Germany)

^c INSERM   (France)

^d NOVARTIS PHARMA AG   (Switzerland)

^e F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Alzheimer's disease; Amyloid precursor protein; Extracellular A deposition; Intracellular A ; Mitochondrial dysfunction; Neuritic plaques; Oxidative stress; Presenilin 1; Transgenic mouse models

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BIOCHEMICAL MARKER; CYTOCHROME C; CYTOCHROME C OXIDASE; CYTOCHROME C OXIDASE 1; ISOENZYME; MANGANESE SUPEROXIDE DISMUTASE; PRESENILIN 1; PROTEIN BAX; UBIQUITIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DYSTROPHY; IMMUNOREACTIVITY; MOUSE; NERVE CELL LESION; NERVE FIBER GROWTH; NEURITE; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUALITATIVE ANALYSIS; TRANSGENIC MOUSE;

EID: 0344826476     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4886(03)00252-8     Document Type: Article

References (75)

1. Beal M.F. Mitochondrial dysfunction in neurodegenerative diseases. Biochem. Biophys. Acta. 1366:1998;211-223.
2. Borchelt D.R., Ratowitski T., VanLare J., Lee M.K., Gonzales V., Jenkins N.A., Copeland N.G., Price D.L., Sisodia S.S. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron. 19:1997;939-945.
3. Boutajangout A., Leroy K., Touchet N., Authelet M., Blanchard V., Tremp G., Pradier L., Brion J.-P. Increased tau phosphorylation but absence of formation of neurofibrillary tangles in mice double transgenic for human tau and Alzheimer mutant (M146L) presenilin-1. Neurosci. Lett. 318:2002;29-33.
4. Boutajangout, A., Authelet, M., Blanchard, V., Touchet, N., Tremp, G., Pradier, L., Brion, J.-P., 2002b. Cytoskeletal abnormalities in mice transgenic for human tau and mutants APP and presenilin-1, submitted for publication.
5. Bugiani O., Giaccone G., Verga L., Pollo B., Ghetti B., Frangione B., Tagliavini F. Alzheimer patients and down patients abnormal presynaptic terminals are related to cerebral preamyloid deposits. Neurosci. Lett. 119:1990;56-59.
6. Busciglio J., Pelsman A., Wong C., Pigino G., Yuan M., Mori H., Yankner B. Altered metabolism of the amyloid β precursor protein is associated with mitochondrial dysfunction in Down's Syndrome. Neuron. 33:2002;677-688.
7. Chishti M.A., Yang D.S., Janus C., Phinney A.L., Horne P., Pearson J., Strome R., Zuker N., Loukides J., French J., Turner S., Lozza G., Grilli M., Kunicki S., Morissette C., Paquette J., Gervais F., Bergeron C., Fraser P.E., Carlson G.A., George-Hyslop P.S., Westaway D. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J. Biol. Chem. 276:2001;21562-21570.
8. Chui D.H., Tanahashi H., Ozawa K., Ikeda S., Checler F., Ueda O., Suzuki H., Araki W., Inoue H., Shirotani K., Takahashi K., Gallyas F., Tabira T. Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation. Nature Med. 5:1999;560-564.
9. Chui D.H., Dobo E., Mafikuchi T., Akiyama H., Kawakatsu S., Petit A., Checler F., Araki W., Takahashi K., Tabira T. Apoptotic neurons in Alzheimer's Disease frequently show intracellular Aβ42 labelling. J. Alzheimer's Dis. 3:2001;231-239.
10. Cras P., Kawai M., Lowery D., Gonzalez-DeWhitt P., Greenberg B., Perry G. Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. Proc. Natl. Acad. Sci. USA. 88:1991;7552-7556.
11. Czech C., Delaere P., Macq A.-F., Dreisler S., Touchet N., Schombert B., Mazadier M., Mercken L., Theisen M., Pradier L., Octave J.-N., Beyreuther K., Tremp G. Proteolytical processing of mutated human amyloid protein precursor in transgenic mice. Mol. Brain Res. 47:1997;108-116.
12. Czech C., Tremp G., Pradier L. Presenilins and Alzheimer's disease biological functions and pathogenic mechanisms. Pro. Neurobiol. 60:2000;363-384.
13. Cummings B.J., Su J.H., Geddes J.W., Van Nostrand W.E., Wagner S.L., Cunningham D.D., Cotman C.W. Aggregation of the amyloid precursor protein within degenerating neurons and dystrophic neurites in Alzheimer's disease. Neuroscience. 48:1992;763-777.
14. D'Andrea M.R., Nagele R.G., Wang H.-Y., Peterson P.A., Lee D.H.S. Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease. Histopathology. 38:2001;120-134.
15. Dewachter I., Van Dorpe J., Smeijers L., Gilis M., Kuiperi C., Laenen I., Caluwaerts N., Moechars D., Checler F., Vanderstichele H., Van Leuven F. Aging increased amyloid peptide and caused amyloid plaques in brain of old APP/V7171 transgenic mice by a different mechanism than mutant presenilin1. J. Neurosci. 20:2000;6452-6458.
16. Dickson T.C., King C.E., McCormack G.H., Vickers J.C. Neurochemical diversity of dystrophic neurites in the early and late stages of Alzheimer's disease. Exp. Neurol. 1:1999;100-110.
17. Franklin K.B.J., Paxinos G. The Mouse Brain in Stereotaxic Coordinates. 1997;Academic Press, San Diego.
18. Furuta A., Price D.L., Pardo C.A., Troncoso J.C., Xu Z.-S., Taniguchi N., Martin L.J. Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus. Am. J. Pathol. 146:1995;357-367.
19. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature. 373:1995;523-527.
20. Goedert M., Jakes R., Crowther R.A., Cohen P., Vanmechelen E., Vandermeeren M., Cras P. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease identification of phosphorylation sites in tau protein. J. Biochem. 301:1994;871-877.
21. Gouras G.K., Tsai J., Naslund J., Vincent B., Edgar M., Checler F., Greenfield J.P., Haroutunian V., Buxbaum J.D., Xu H., Greengard P., Relkin N.R. Intraneuronal Aβ42 accumulation in human brain. Am. J. Pathol. 156:2000;15-20.
22. Guenette S.Y., Tanzi R.E. Progress toward valid transgenic mouse models for Alzheimer's disease. Neurobiol. Aging. 20:1999;201-211.
23. Holcomb L., Gordon M.N., McGowan E., Yu X., Benkovic S., Jantzen P., Wright K., Saad I., Mueller R., Morgan D., Sanders S., Zehr C., O'Campo K., Hardy J., Prada C.M., Eckman C., Younkin S., Hsiao K., Duff K. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant APP and presenilin 1 transgenes. Nature Med. 4:1998;97-100.
24. Hsia A.Y., Masliah E., McConlogue L., Yu G.Q., Tatsuno G., Hu K., Kholodenko D., Malenka R.C., Nicoll R.A., Mucke L. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. USA. 96:1999;3228-3233.
25. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
26. Irizarry M.C., Soriano F., McNamara M., Page K.J., Schenk D., Games D., Hyman B.T. Aβ deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J. Neurosci. 17:1997;7053-7059.
27. Khorkova O.E., Patel K., Heroux J., Sahasrabudhe S. Modulation of amyloid precursor protein processing by compounds with various mechanisms of action detection by liquid phase electrochemiluminescent system. J. Neurosci. Methods. 82:1998;159-166.
28. Kim K.S., Miller D.L., Sapinza V.J., Chen C.J., Bai C., Grundke-Iqbal I., Currie J.R., Wisniewski H.M. Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptie. Neurosci. Res. Commun. 2:1988;121-130.
29. Kish S.J., Bergeron C., Rajput A., Dozic S., Mastrogiacomo F., Chang L.J., Wilson J.M., DiStefano L.M., Nobrega J.N. Brain cytochrome oxidase in Alzheimer's disease. J. Neurochem. 59:1992;776-779.
30. Kitamura Y., Shimohama S., Kamoshima W., Ota T., Matsuoka Y., Nomura Y., Smith M.A., Perry G., Whitehouse P.J., Taniguchi T. Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease. Brain Res. 780:1998;260-269.
31. LaFerla F.M., Troncoso J., Strickland D.K., Kawas C.H., Jay G. Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Abeta stabilization. J. Clin. Invest. 100:1997;310-320.
32. Leutner S., Czech C., Schindowski K., Touchet N., Eckert A., Mueller W.E. Reduced antioxidant enzyme activity in brains of mice transgenic for human presenilin-1 with single or multiple mutations. Neurosci. Lett. 292:2000;87-90.
33. MacGibbon G.A., Lawlor P.A., Sirimanne E.S., Walton M.R., Connor B., Young D., Williams C., Gluckman P., Faull R.L., Hughes P., Dragunow M. Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer's disease hippocampus. Brain Res. 750:1997;223-234.
34. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radical Biol. Med. 23:1997;134-147.
35. McGowan E., Sanders S., Iwatsubo T., Takeuchi A., Saido T., Zehr C., Yu X., Uljon S., Wang R., Mann D., Dickson D., Duff K. Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes. Neurobiol. Dis. 6:1999;231-244.
36. Masliah E., Mallory M., Deerinck T., DeTeresa R., Lamont S., Miller A., Terry R.D., Carragher B., Ellisman M. Re-evaluation of the structural organization of neuritic plaques in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 52:1993;619-632.
37. Masliah E., Mallory M., Hansen L., DeTeresa R., Alford M., Terry R. Synaptic and neuritic alterations during the progression of Alzheirmer's disease. Neurosci. Lett. 174:1994;67-72.
38. Masliah E., Sisk A., Mallory M., Mucke L., Schenk D., Games D. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F β-amyloid precursor protein and Alzheimer's disease. J. Neurosci. 16:1996;5795-5811.
39. Masliah E., Sisk A., Mallory M., Games D. Neurofibrillary pathology in transgenic mice overexpressing V717F β-amyloid precursor protein. J. Neuropathol. Exp. Neurol. 60:2001;357-368.
40. Matsuoka Y., Picciano M., Maleste B., LaFrancois J., Zehr C., Daeschner J.M., Olschowka J.A., Fonseca M.I., O'Banion M.K., Tenner A.J., Lemere C.A., Duff K. Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease. Am. J. Pathol. 158:2001;1345-1354.
41. Moechars D., Lorent K., De Strooper B., Dewachter I., Van Leuven F. Expression in brain of amyloid precursor protein mutated in the alpha-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice. EMBO J. 15:1996;1265-1274.
42. Moechars D., Dewachter I., Lorent K., Reversé D., Baekelandt V., Naidu A., Tesseur I., Spittaels K., Van Den Haute C., Checler F., Godaux E., Cordell B., Van Leuven F. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J. Biol. Chem. 274:1999;6483-6492.
43. Mohajeri M.H., Saini K., Schultz J.G., Wollmer M.A., Hock C., Nitsch R.M. Passive immunization against β-amyloid peptide protects central nervous system (CNS) neurons from increased vulnerability associated with an Alzheimer's disease- causing mutation. J. Biol. Chem. 227:2002;33012-33017.
44. Mutisya E.M., Bowling A.C., Beal M.F. Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J. Neurochem. 63:1994;2179-2184.
45. Nagy Z.S., Esiri M. Apoptosis-related protein expression in the hippocampus in Alzheimer's disease. Neurobiol. Aging. 18:1997;565-571.
46. Pappolla M.A., Omar R.A., Kim K.S., Robakis N.K. Immunohistochemical evidence of oxidative stress in Alzheimer's disease. Am. J. Pathol. 140:1992;621-628.
47. Pappolla M.A., Chyan Y.J., Omar R.A., Hsiao K., Perry G., Smith M.A., Bozner P. Evidence of oxidative stress and in vivo neurotoxicity of β-Amyloid in a transgenic mouse model of Alzheimer's disease a chronic oxidative paradigm for testing antioxidant therapies in vivo. Am. J. Pathol. 152:1998;871-877.
48. Phinney A.L., Deller T., Stalder M., Calhoun M.E., Frotscher M., Sommer B., Staufenbiel M., Jucker M. Cerebral amyloid induces aberrant axonal sprouting and ectopic terminal formation in amyloid precursor protein transgenic mice. J. Neurosci. 19:1999;8552-8559.
49. Pradier L., Carpentier C., Delalonde L., Clavel N., Bock M.-D., Buée L., Mercken L., Tocqué B., Czech C. Mapping the APP/presenilin (PS) binding domains the hydrophilic N-terminus of PS2 is sufficient for interaction with APP and can displace APP/PS1 interaction. Neurobiol. Dis. 6:1999;43-55.
50. Pratico D., Uryu K., Leight S., Trojanoswki J.Q., Lee V.M.-Y. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J. Neurosci. 21:2001;4183-4187.
51. Price D.L., Sisodia S.S. Mutant genes in familial Alzheimer's disease and transgenic models. Annu. Rev. Neurosci. 21:1998;479-505.
52. Sawamura N., Morishima-Kawashima M., Waki H., Kobayashi K., Kuramochi T., Frosch M.P., Ding K., Ito M., Kim T.W., Tanzi R.E., Oyama F., Tabira T., Ando S., Ihara Y. Mutant Presenilin 2 transgenic mice. A large increase in the levels of Abeta 42 is presumably associated with the low density membrane domain that contains decreased levels of blycerophospholipids and sphingomyelin. J. Biol. Chem. 275:2000;27901-27908.
53. Shoji M., Iwakami N., Takeuchi S., Waragai M., Suzuki M., Kanazawa M., Lippa C.F., Ono S., Okazawa H. JNK activation is associated with intracellular beta- amyloid accumulation. Mol. Brain Res. 85:2000;221-233.
54. Smith M.A., Kutty R.K., Richey P.I., Yan S.D., Stern D., Chader G.J., Wiggert B., Petersen R.B., Perry G. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am. J. Pathol. 145:1994;42-47.
55. Smith M.A., Hirai K., Hsiao K., Pappolla M.A., Harris P.L., Siedlak S.L., Tabaton M., Perry G. Amyloid deposition in Alzheimer transgenic mice is associated with oxidative stress. J. Neurochem. 70:1998;2212-2215.
56. Smith M.A., Drew K.L., Nunomura A., Takeda A., Hirai K., Zhu X., Atwood C.S., Raina A.K., Rottkamp C.A., Sayre L.M., Friedland R.P., Perry G. Amyloid-β, tau alterations and mitochondrial dysfunction in Alzheimer disease the chickens or the eggs. Neurochem. Int. 4:2002;527-531.
57. Sturchler-Pierrat C., Abramowski D., Duke M., Wiederhold K.-H., Mistl C., Rothacher S., Ledermann B., Bürki K., Frey P., Paganetti P.A., Waridel C., Calhoun M.E., Jucker M., Probst A., Staufenbiel M., Sommer B. Two amyloid precursor protein transgenic mouse models with Alzheimer disease like pathology. Proc. Natl. Acad. Sci. USA. 94:1997;13287-13292.
58. Su J.H., Cummings B.J., Cotman C.W. Plaque biogenesis in brain aging and Alzheimer's disease. I. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments. Brain Res. 739:1996;79-87.
59. Su J.H., Deng G., Cotman C.W. Bax protein expression is increased in Alzheimer's brain correlations with DNA damage, Bcl-2 expression and brain pathology. J. Neuropathol. Exp. Neurol. 56:1997;86-93.
60. Su J.H., Cummings B.J., Cotman C.W. Plaque biogenesis in brain aging and Alzheimer's disease. II. Progressive transformation and developmental sequence of dystrophic neurites. Acta Neuropathol. 96:1998;463-471.
61. Takahashi R.H., Milner T.A., Li F., Nam E.E., Edgar M.A., Yamaguchi H., Beal M.F., Xu H., Greengard P., Gouras G.K. Intraneuronal Alzheimer Aβ42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am. J. Pathol. 161:2002;1869-1879.
62. Tatton W.G., Chalmers-Redman R.M. Mitochondria in neurodegenerative apoptosis an opportunity for therapy? Ann. Neurol. 44:(Suppl 1):1998;S134-S141.
63. Thal D.R., Hartig W., Schober R. Stage-correlated distribution of type 1 and 2 dystrophic neurites in cortical and hippocampal plaques in Alzheimer's disease. J. Hirnforsch. 39:1998;175-181.
64. Tomidokoro Y., Harigaya Y., Matsubara E., Ikeda M., Kawarabayashi T., Shirao T., Ishiguro K., Okamoto K., Younkin S.G., Shoji M. Brain Aβ amyloidosis in APPsw mice induces accumulation of presenilin-1 and tau. J. Pathol. 194:2001;500-506.
65. Tortosa A., Lopez E., Ferrer I. Bcl-2 and Bax protein expression in Alzheimer's disease. Acta Neuropathol. 95:1998;407-412.
66. Urbanc B., Cruz L., Le R., Sanders J., Hsia Ashe K., Duff K., Stanley H.E., Irizarry M.C., Hyman B.T. Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease. Proc. Natl Acad. Sci. USA. 99:2002;13990-13995.
67. Vickers J.C., Chin D., Edwards A.-M., Sampson V., Harper C., Morrison J. Dystrophic neurite formation associated with age-related β amyloid deposition in the neocortex clues to the genesis of neurofibrillary pathology. Exp. Neurol. 141:1996;1-11.
68. Wang D., Munoz D.G. Qualitative and quantitative differences in senile plaque dystrophic neurites of Alzheimer's disease and normal aged brain. J. Neuropathol. Exp. Neurol. 54:1995;548-556.
69. Wengenack T.M., Whelan S., Curran G.L., Duff K.E., Poduslo J.F. Quantitative histological analysis of amyloid deposition in Alzheimer's double transgenic mouse brain. Neuroscience. 101:2000;934-944.
70. Wirths O., Multhaup G., Czech C., Blanchard V., Moussaoui S., Tremp G., Pradier L., Beyreuther K., Bayer T.A. Intraneuronal Aβ accumulation precedes plaque formation in β-amyloid precursor protein and presenilin-1 double-transgenic mice. Neurosci. Lett. 306:2001;116-120.
71. Wirths O., Multhaup G., Czech C., Feldmann N., Blanchard V., Tremp G., Beyreuther K., Pradier L., Bayer T.A. Intraneuronal APP/Aβ trafficking and plaque formation in β-amyloid precursor protein and presenilin-1 transgenic mice. Brain Pathol. 12:2002;275-286.
72. Yamamoto T., Hirano A. A comparative study of modified Bielschowsky, Bodian and thioflavin S stains on Alzheimer's neurofibrillary tangles. Neuropathol. Appl. Neurobiol. 12:1986;3-9.
73. Yang H., Leland J.K., Yost D., Massey J. Electrochemiluminescence a new diagnostic and research tool. ECL detection technology promises scientists new "yardsticks" for quantification. Biotechnology. 12:1994;193-194.
74. Yankner B.A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron. 16:1996;921-932.
75. Yilmazer-Hanke D.M. Pathogenesis of Alzheimer-related neuritic plaques AT8 immunoreactive dystrophic neurites precede argyrophilic neurites in plaques of the entorhinal region, hippocampal formation, and amygdala. Clin. Neuropathol. 17:1998;194-198.